Roser Ferrer Costa Director of the Clinical Laboratories and Head of the Clinical Biochemistry Service of the Clinical Laboratories of the Vall d’Hebron University Hospital, as well as Head of the Clinical Biochemistry, Drug Delivery and Research Therapy Group of the VHIR. I coordinate the six services that make up the Clinical Laboratories, with a team of professionals oriented to the development of care, teaching, research and innovation, within a common project focused on excellence. Based on a transversal and highly automated model, with highly specialized laboratories we offer a diagnosis of maximum precision and promote innovation in laboratory medicine, incorporating artificial intelligence technologies to advance the diagnosis and prevention of diseases. I have a PhD in Biomedicine from the UB, a specialist in the knowledge area of Clinical Biochemistry of Hormones, a master's degree in Management of Healthcare Institutions and, currently, an associate professor at the UAB. Institutions of which they are part Head of group Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Head of Department Bioquímica Cross-departmental services LinkedIn Twitter Orcid Roser Ferrer Costa LinkedIn Twitter Orcid Institutions of which they are part Head of group Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Head of Department Bioquímica Cross-departmental services Director of the Clinical Laboratories and Head of the Clinical Biochemistry Service of the Clinical Laboratories of the Vall d’Hebron University Hospital, as well as Head of the Clinical Biochemistry, Drug Delivery and Research Therapy Group of the VHIR. I coordinate the six services that make up the Clinical Laboratories, with a team of professionals oriented to the development of care, teaching, research and innovation, within a common project focused on excellence. Based on a transversal and highly automated model, with highly specialized laboratories we offer a diagnosis of maximum precision and promote innovation in laboratory medicine, incorporating artificial intelligence technologies to advance the diagnosis and prevention of diseases. I have a PhD in Biomedicine from the UB, a specialist in the knowledge area of Clinical Biochemistry of Hormones, a master's degree in Management of Healthcare Institutions and, currently, an associate professor at the UAB.
Healthcare Activity: Since 2007 I have been working in healthcare at the University Hospital, where I trained as a specialist in Clinical Biochemistry (2003). I am a pharmacist by training and until 2019 I was responsible for the Hormone Process (Endocrine Pathology) of the same Service and later Head of Section of the Automated Laboratory. Since 2023 I have been Head of the Clinical Biochemistry Service and in 2025 I have been appointed Clinical Director of the Clinical Laboratories. The Clinical Biochemistry Service is part of the Clinical Laboratories of the Vall d'Hebron University Hospital, which also provides in vitro diagnosis coverage to the entire population, with public healthcare, of the city of Barcelona (1.5 million people). In 2019 I completed a master's degree in Healthcare Institution Management, I have training in healthcare processes and specialized in automation, concepts that I try to apply in my usual practice and in the Service. Finally, I am the secretary of the hospital's In Vitro Diagnostics Commission. Research Activity: I have a PhD in Biomedicine from the University of Barcelona (2015) and Group Leader of Clinical Biochemistry, Drug Delivery and Research Therapy at the Research Institute of the Vall d'Hebron University Hospital since 2023. In recent years I have actively participated in different publications of the Service itself and in collaboration with research groups and services of the hospital. Associate of the eCore Personalized Medicine, Innovative Diagnostics, Molecular Imaging & Digital Health of the VHIR. I am President of the Catalan Association of Clinical Laboratory Sciences (since June 2021) and President of the Hormones Commission (since 2023) and of the Executive Committee (since 2018) of the Spanish Society of Laboratory Medicine (Semedlab). Teaching Activity: I am currently an Associate Professor at the Autonomous University of Barcelona in the Department of Biochemistry and Molecular Biology, Medical Biochemistry Unit. I participate in the postgraduate supervision of doctoral theses in the Biochemistry Service.
Projects (HEPAST) - Estrategias de terapia genica para controlar la infeccion por los virus de la Hepatitis B y Delta basada en el estudio de las cuasiespecies virales por secuenciación masiva IP: - Collaborators: Roser Ferrer Costa Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 157300 Reference: PID2021-126447OB-I00 Duration: 01/09/2022 - 31/08/2025 Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT) IP: - Collaborators: José Antonio Arranz Amo, Raquel Barquin Del Pino, Laura Conesa Milian, Clara Ramírez Serra, Yolanda Villena Ortiz, Joan López Hellin, Albert Blanco Grau, Roser Ferrer Costa, Joaquin Seras Franzoso, Diego Baranda Martínez-Abasca, Laura Castillo Ribelles, Clara Carnicer Cáceres, Marina Giralt Arnaiz, Ana Gomez Garcia, Simon Schwartz Navarro, Pablo Gabriel Medina, Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Laura Castellote Bellés, Daniel Bravo Nieto, Luz María Cruz Carlos, Clara Sanz Gea, Alba Estela García Fernández, Maria del Pilar Reimundo Diaz-Fierros, Belen Garcia Prats, Noelia Díaz Troyano, JAUME VIMA BOFARULL, Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Diana Fernandes de Rafael, Maria Francesca Cortese, Sandra Mancilla Zamora Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 60000 Reference: 2021 SGR 01173 Duration: 01/01/2022 - 30/06/2025 COVID-19, PERFIL INMUNOLÓGICO DE RIESGO IP: - Collaborators: Manuel Hernández González, Mónica Martínez Gallo, Moisés Labrador Horrillo, Gema Codina Grau, Albert Blanco Grau, Andres Antón Pagarolas, Antonio Álvarez Fernandez, Nuria Fernández Hidalgo, Roser Ferrer Costa, Esteve Ribera Pascuet, Juan Carlos Ruiz Rodriguez, Jaume Ferrer Sancho, Anna Suy Franch, Pere Soler Palacín, Albert Selva O'Callaghan, Tomàs Pumarola Suñé, Isabel Ruiz Camps, Daniel Alvarez De la Sierra, Andrea Martín Nalda, Eva Polverino, Romina Dieli Crimi, Romina Dieli Crimi Funding agency: Instituto de Salud Carlos III Funding: 229000 Reference: COV20/00416 Duration: 08/05/2020 - 08/11/2021 RECEPTORES INHBITORIOS (NEGATIVE IMMUNE CHECKPOINT RECEPTORS, NCRs) EN AUTOINMUNIDAD TIROIDEA Y CANCER, NUEVAS VÍAS TERAPÉUTICAS EN AUTOINMUNIDAD IP: - Collaborators: Oscar González López, Roser Ferrer Costa, Carmela Iglesias i Felip, Anna Casteras Román, Elena Garralda Cabanas, Daniel Alvarez De la Sierra Funding agency: Instituto de Salud Carlos III Funding: 147620 Reference: PI17/00324 Duration: 01/01/2018 - 30/06/2022 Pagination First page « Previous page ‹ Page 1 Current page 2 Page 3 Next page › Last page »
